Engineering Microenvironments for Stem Cells - Panel Discussion
This panel will discuss the use of tissue engineering techniques for controlling the stem cell microenvironment with the ultimate goals of improving stem cel...
By: Alliance for Regenerative Medicine
View post:
Engineering Microenvironments for Stem Cells - Panel Discussion - Video
Engineering Microenvironments for Stem Cells - Adam Engler, UC San Diego
Speaker: Adam Engler, Ph.D., Associate Professor, Department of Bioengineering, UC San Diego.
By: Alliance for Regenerative Medicine
Here is the original post:
Engineering Microenvironments for Stem Cells - Adam Engler, UC San Diego - Video
Research in pluripotent stem cells | Anna Veiga | TEDxReus
This talk was given at a local TEDx event, produced independently of the TED Conferences. What are stem cells? What is the current research and what are the ...
By: TEDx Talks
Go here to read the rest:
Research in pluripotent stem cells | Anna Veiga | TEDxReus - Video
The Binding of Isaac: Rebirth Unlimited Fart Sound Glitch
I played the FART SNDS seed and a bug happened, ED, or tyrone... Tyrone is a black name but he is Hispanic but appears to be white skin... Stem Cells The Binding of Isaac: Rebirth https://store.so...
By: djsponge10
Visit link:
The Binding of Isaac: Rebirth Unlimited Fart Sound Glitch - Video
Treating Eye Diseases With Stem Cells
http://www.naturalclearvision.com/go/... If you are concerned about eye disease , please click on this link to better understand all of you.
By: Health
Read more here:
Treating Eye Diseases With Stem Cells - Video
DoJiggy Giving Contest - Help us win $1,000 for mesothelioma research
The Pacific Meso Center is researching harnessing the potential of mesenchymal stem cells for cancer therapy. Mesenchymal stem cells can serve as a vehicle for delivering a wide range of molecular...
By: Pacific Heart, Lung Blood Institute
Here is the original post:
DoJiggy Giving Contest - Help us win $1,000 for mesothelioma research - Video
MIAMI (PRWEB) November 11, 2014
GlobalStemCellsGroup, Inc. has announced plans to host a minimum of four international symposiums on stem cell research in 2015. The symposiums will be held in three Latin American countriesChile, Mexico and Colombiain which Global Stem Cells has established state-of-the-art stem cell clinics staffed with expert medical personnel trained in regenerative medicine, through the Regenestem Network.
The fourth symposium will be held in Miami.
The decision follows the success of the Global Stem Cells Groups first International Symposium on Stem Cells and Regenerative Medicine, held Oct. 2, 3 and 4 in Buenos Aires, Argentina. Global Stem Cells Group CEO Benito Novas says the Buenos Aires event, combined with its steady growth of new clinics throughout Latin America, has provided additional motivation to schedule more stem cell symposiums in an effort to further educate the medical community on the latest advancements in stem cell therapies.
Thanks to Global Stem Cells Groups growing network of world-class stem cell researchers, treatment practitioners and investors committed to advancing stem cell medicine, the company is rapidly moving closer to its goal of helping physicians to bring treatments into their offices for the benefit of patients.
More than 900 physicians, researchers and regenerative medicine experts from around the world attended the Buenos Aires symposium, and Novas expects that number to grow with upcoming conferences.
We will continue to bring together a variety of committed stem cell advocates from the U.S., Mexico, Greece, Hong Kong and other regions around the globe, to be joined by a team of knowledgeable speakers, each one presenting the future of regenerative medicine in their field of specialty, Novas says.
Regenerative medicine as a field is still in its infancy, according to Global Stem Cell Group President and CEO Benito Novas.
Our objective is to [open a dialogue among the worlds medical and scientific communities in order to advance stem cell technologies and translate them into point of care medicine to the best of out abilities, Novas says. Our mission is to bring the benefits of stem cell therapies to the physicians office safely, efficacy and compliance with the highest standards of care with safety, efficacy and complying with the highest standard of care the world has to offer.
The purpose of each symposium is to bring top stem cell scientists together to share their knowledge and expertise in regenerative medicine, and begin the process of separating myths from facts when it comes to stem cell science and technology.
See original here:
Global Stem Cells Group Announces Plans to Hold Four International Symposiums on Stem Cells and Regenerative Medicine ...
PUBLIC RELEASE DATE:
10-Nov-2014
Contact: Ccile Martinat CMARTINAT@istem.fr 33-603-855-477 INSERM (Institut national de la sant et de la recherche mdicale) @inserm
This news release is available in French.
The motor neurons that innervate muscle fibres are essential for motor activity. Their degeneration in many diseases causes paralysis and often death among patients. Researchers at the Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem - Inserm/AFM/UEVE), in collaboration with CNRS and Paris Descartes University, have recently developed a new approach to better control the differentiation of human pluripotent stem cells, and thus produce different populations of motor neurons from these cells in only 14 days. This discovery, published in Nature Biotechnology, will make it possible to expand the production process for these neurons, leading to more rapid progress in understanding diseases of the motor system, such as infantile spinal amyotrophy or amyotrophic lateral sclerosis (ALS).
Human pluripotent stem cells have the ability to give rise to every cell in the body. To understand and control their potential for differentiation in vitro is to offer unprecedented opportunities for regenerative medicine and for advancing the study of physiopathological mechanisms and the quest for therapeutic strategies. However, the development and realisation of these clinical applications is often limited by the inability to obtain specialised cells such as motor neurons from human pluripotent stem cells in an efficient and targeted manner. This inefficiency is partly due to a poor understanding of the molecular mechanisms controlling the differentiation of these cells.
Inserm researchers at the Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem - Inserm/French Muscular Dystrophy Association [AFM]/University of vry Val d'Essonne [UEVE]), in collaboration with CNRS and Paris-Descartes University, have developed an innovative approach to study the differentiation of human stem cells and thus produce many types of cells in an optimal manner.
"The targeted differentiation of human pluripotent stem cells is often a long and rather inefficient process. This is the case when obtaining motor neurons, although these are affected in many diseases. Today, we obtain these neurons with our approach in only 14 days, nearly twice as fast as before, and with a homogeneity rarely achieved," explains Ccile Martinat, an Inserm Research Fellow at I-Stem.
To achieve this result, the researchers studied the interactions between some molecules that control embryonic development. These studies have made it possible to both better understand the mechanisms governing the generation of these neurons during development, and develop an optimal "recipe" for producing them efficiently and rapidly.
"We are now able to produce and hence study different populations of neurons affected to various degrees in diseases that cause the degeneration of motor neurons. We plan to study why some neurons are affected and why others are preserved," adds Stphane Nedelec, an Inserm researcher in Ccile Martinat's team.
Follow this link:
Production of human motor neurons from stem cells is gaining speed
The day Olivia Cox was diagnosed with Type 1 diabetes at age 16, her mother vowed to find a cure.
"I said to her, "there's someone walking this Earth who has been cured of diabetes, and I'm going to find him," Ruth Cox said.
Cox's search started with a call to Harvard University and ended with a family trip to Lima, Peru. It was at a clinic there that now 18-year-old Olivia and her father, Jeff, 54, who also has diabetes, received an infusion of stem cells designed to wipe out diabetes in their bodies or, at the very least, lessen its impact. The treatment illegal in the United States cost $70,000 for both father and daughter. Two months later, the Niskayuna family is waiting for a transformation and wondering if, in their desperation for a cure, they were snookered by false promises.
Because stem cells can be programmed to become anything from heart muscle to toenails, stem cell therapy can hypothetically be used to treat anything, from baldness to Lou Gehrig's Disease. But the study of regenerative medicine is still nascent in the United States, where it is restricted to procedures that use the patient's own cells, and it has been primarily used in treating cancer a procedure that saved Ruth Cox 13 years ago, when she had breast cancer.
Stem cell treatment using donor cells is more common elsewhere in the world, but with varying results and none that could be described as a cure. An executive order from President Barack Obama opened up funding for stem cell research and there are now more than 4,000 clinical trials under way, some on animals and some recruiting people with various ailments.
The American Diabetes Association strongly supports stem cell research, according to a statement posted on its website, which reads in part:
"Scientists from across the United States and throughout the world, including those involved with the American Diabetes Association believe that stem cell research, especially embryonic stem cell research, holds great promise in the search for a cure and better treatments for diabetes."
Jeff Cox, diagnosed with Type 1 diabetes when he was 11, has suffered none of the complications that often come with the disease neuropathy, loss of vision and heart disease. But Cox said living with diabetes is hell. He pricks his finger at least a dozen times a day to check his blood sugar level, because it is a more precise reading than the glucose monitor he wears. He also wears a pump that he programs to inject him with insulin automatically based on his diet and exercise each day. All the therapies used to treat diabetes are designed to intervene where the pancreas has gone awry.
In Type 1 diabetes, the pancreas doesn't produce insulin due to an autoimmune attack against the beta cell that produces insulin the hormone that converts glucose into energy our bodies need to survive. The Coxes didn't want their daughter to face a lifetime of managing her diabetes. They wanted a cure, and they were willing to take a risk to find it.
In order to treat diabetes with stem cell therapy, pancreatic stem cells isolated from umbilical cord blood that are programmed to produce insulin, plus autologous mesenchymal stem cells from the patient's bone marrow, are injected. Once in the pancreas, the cells are supposed to replicate themselves, gradually replacing the non-insulin producing cells in the host's pancreas. The treatment is conducted in Peru, China, Russia and India and elsewhere, but Zubin Master, a bioethicist at Albany Medical College, said the risks of traveling abroad for stem cell therapy range from paying for an expensive treatment that doesn't work, to cancer and death.
See original here:
Family's desperate bet on a diabetes cure
Why Stem Cells Aren #39;t Being Tested in the US
Stem cell treatment is restricted in the United States, and we discuss the reasons the FDA has been so restrictive about the game-changing research and therapy with Dr. Neil Riordan. Patent...
By: TheLipTV
Go here to read the rest:
Why Stem Cells Aren't Being Tested in the US - Video
Engineering Microenvironments for Stem Cells - Shaochen Chen, UC San Diego
Speaker: Shaochen Chen, Ph.D., Professor, NanoEngineering Bioengineering; Co-Director, Biomaterials Tissue Engineering Center, UC San Diego.
By: Alliance for Regenerative Medicine
Read more from the original source:
Engineering Microenvironments for Stem Cells - Shaochen Chen, UC San Diego - Video
kineticvideo.com - Biotech 21st ethics-of-biotechnology-12540-4
Genetically modified?! Stem cell medical breakthrough!? More people living longer? More (healthy?) food from cloned animals and altered crops? Where is BIOTE...
By: Kineticstreaming
View post:
kineticvideo.com - Biotech 21st ethics-of-biotechnology-12540-4 - Video
Clinical Trials: Advanced Cell Technology - Stem Cell Therapy
Last month (October 2014) in The Lancet, Advanced Cell Technology (ACT) published their preliminary phase 1 clinical data for their Stem Cell therapy trials for Stargardt #39;s Macular Dystrophy...
By: Essceejulies
Original post:
Clinical Trials: Advanced Cell Technology - Stem Cell Therapy - Video
Magnifisio dashed home strongly over 1400m to win Saturdays Lee-Steere Stakes at Ascot. Picture: Westernracepix
Sprinter Smoko will have stem cell therapy at Murdoch Veterinary Hospital to a strained suspensory ligament in his off-foreleg.
Vets found Smoko had strained the ligament when he pulled up sore following his shock sixth as a $2 favourite to Shining Knight in last Tuesday's Colonel Reeves Stakes (1100m) at Ascot.
Co-trainer Ross Price said Smoko would be sidelined for months.
"He will go to Murdoch where they will look at him and see about stem cell therapy," he said.
"In about 10 days we will take him up there and see what they can do. It is then going to be five months off and hoping."
Smoko was a $6.50 chance in Saturday week's Winterbottom Stakes (1200m) before he was scratched. WA's hopes of winning back the Group 1 weight-for-age hinge on Magnifisio, Shining Knight and Testamezzo, with Barakey in doubt after struggling to recover from a virus.
"He is still feeling flat and I will have to wait and see if he improves over the next few days," trainer Jim Taylor said.
Magnifisio firmed from $12 into $8 on the TAB yesterday following her strong win at her debut over 1400m in Saturday's Group 2 Lee-Steere Stakes at Ascot.
Melbourne sprinters Angelic Light, Moment Of Change and reigning champion Buffering dominate betting at $4.30, $6.50 and $7.50.
See the original post:
Stem cell therapy for sidelined star Smoko
Dopamine-making neurons derived from human embryonic stem cells.
A rat model of Parkinson's disease has been successfully treated with neurons derived from human embryonic stem cells, according to a study led by Swedish scientists. Its a promising sign for scientists at The Scripps Research Institute and Scripps Health who hope to perform similar therapy on Parkinsons patients, using artificial embryonic stem cells.
In rats and people, neurons that make the neurotransmitter dopamine are essential for normal movement. The cells are destroyed in Parkinson's, leading to the difficulty in movement that characterizes the disease.
Researchers transplanted dopamine-producing cells grown from human embryonic stem cells into the brains of rats whose own dopamine-making neurons had been destroyed. The rats were immune-suppressed so they would not reject the cells. Within five months, the transplanted cells boosted dopamine production to normal levels, restoring normal movement in the rats.
The study was published Thursday in the journal Cell Stem Cell. The senior author was Malin Parmar of Lund University in Lund, Sweden.
The results support the Scripps approach of using the artificial embryonic stem cells, called induced pluripotent stem cells, said Jeanne Loring, who heads the Center for Regenerative Medicine at The Scripps Research Institute in La Jolla. Loring is part of a group called Summit 4 Stem Cell that's raising funds to treat eight Parkinson's patients with their own IPS cells.
Particularly significant is the study's comparison of the effects of dopamine-making neurons derived from fetal cells to that of embryonic stem cells, Loring said by email.
"In the 1980s and 1990s, there were several clinical trials that showed that grafts of fetal brain containing the precursors of dopamine neurons could reverse the effects of Parkinson's disease in some patients," Loring said. "We, and the others developing stem cell therapies, based our plans on the results of those studies, but no one had ever directly compared fetal tissue and human pluripotent stem cell-derived dopamine neurons in an animal model of PD."
Induced pluripotent stem cells appear to have much the same capacity as human embryonic stem cells to generate different tissues and organs.
There has been uncertainty about how similar they are to each other, specifically whether the IPS process produces mutations. But recent studies have found the cell types are extremely similar, including a study also published in Cell Stem Cell on Thursday. That study compared IPS cells with embryonic stem cells produced by SCNT, or somatic cell nuclear transfer, the same process used to create Dolly the sheep.
Read the original post:
Parkinson's stem cell therapy works in rats
Stem cell transplants for Parkinsons disease edging closer
A major breakthrough in the development of stem cell-derived brain cells has put researchers on a firm path towards the first ever stem cell transplantations in people with Parkinson #39;s disease....
By: LundUniversity
View post:
Stem cell transplants for Parkinsons disease edging closer - Video
Stem Cells Help Victim of Spinal Cord Injury to Walk
A young man that was paralyzed after a gunshot wound to the spine, and after 4 weeks of stem cell treatment he regained use of his legs. We look at video of his recovery and speak with his...
By: TheLipTV
Read more here:
Stem Cells Help Victim of Spinal Cord Injury to Walk - Video
Blue Horizon Stem Cells and the Promise of Regenerative Medicine
By: Blue Horizon
Read this article:
Blue Horizon Stem Cells and the Promise of Regenerative Medicine - Video
Adult stem cells: key to regenerative medicine - do you know?
Regenerative medicine is poised to dramatically alter conventional methods of treatment, shifting the focus away from symptoms and targeting the specific causes of different defects. Within...
By: euronews Knowledge
Read more from the original source:
Adult stem cells: key to regenerative medicine - do you know? - Video
Stem Cell Therapy for Pets in Central Florida
http://www.NewmanVets.com Call your local Newman Veterinary Center for more information about stem cell therapy for pets. https://www.youtube.com/watch?v=7X23bmsy0Q8 feature=youtu.be.
By: Newman Veterinary Centers
Continued here:
Stem Cell Therapy for Pets in Central Florida - Video